StonvexLoading…
StonvexStonvexStonvexCore line items from ALTI's most recent SEC filings (10-K / 10-Q via EDGAR XBRL). Last 4 reporting periods.
Quarterly filings sourced directly from SEC EDGAR. Real-time earnings actuals are in the Earnings panel above.
| Metric | Q3 2026 (Est.) Expected 2026-08-10 | Q1 2026 2026-03-31 | Annual 2025 2025-12-31 | Q3 2025 2025-09-30 | Q2 2025 2025-06-30 |
|---|---|---|---|---|---|
Revenue | $66.71M | $73.11M | $254.96M | $166.70M | $111.09M |
Operating Income | Not available | $-10.66M | $-73.94M | $-62.48M | $-43.64M |
Net Income | Not available | $7.70M | $-119.70M | $-106.59M | $-22.45M |
EPS (Diluted) | $0.06 | $0.01 | $-1.23 | $-0.97 | $-0.37 |
Total Assets | Not available | $1.14B | $1.18B | $1.15B | $1.24B |
Total Liabilities | Not available | $255.69M | $301.66M | $270.59M | $252.58M |
Cash & Equivalents | Not available | $39.72M | $41.16M | $35.85M | $42.41M |
Free Cash Flow OCF − CapEx | Not available | $5.31M | $-52.24M | $-54.33M | $-50.92M |
Shares Outstanding | Not available | 110.88M | 99.87M | 98.99M | 97.41M |